Session 118 - CROI 2009

Session 118 Poster Abstracts
Transmission of Drug-resistant HIV
Tuesday, 1-2:30 pm
Poster Hall

672	Persistence of Transmitted Drug-resistance Mutations in Patients with Acute HIV Vivek Jain*¹, C Susupira², S Deeks¹, T Liegler¹, C Pilcher¹, R Grant³, E Kallas², R Cortes², R Diaz², and F Hecht¹ ¹San Francisco Gen Hosp, Univ of California, San Francisco, US; ²Federal Univ of Sao Paulo, Brazil; and ³Gladstone Inst of Virology and Immunology, San Francisco, CA, US
673	Increasing Prevalence of NNRTI-associated Drug-resistance Mutations in Patients with Acute, Early HIV in San Francisco Vivek Jain*¹, C Pilcher¹, S Deeks¹, T Liegler¹, W Hartogensis¹, T Schmidt¹, L Loeb¹, L Poole¹, R Grant², and F Hecht¹ ¹San Francisco Gen Hosp, Univ of California, San Francisco, US and ²Gladstone Inst of Virology and Immunology, San Francisco, CA, US
674	Prevalence of Low-level Mutations in Primary HIV-1 Infection and Its Effect on ART J Stekler¹, G Ellis², J Carlsson², B Eilers¹, S Holte^1,3, Janine Maenza*¹, C Stevens¹, A Collier¹, and L Frenkel^1,2 ¹Univ of Washington, Seattle, US; ²Seattle Children`s Hosp, WA, US; and ³Fred Hutchinson Cancer Res Ctr, Seattle, WA, US
675	Demonstration of Sustained Drug-resistant HIV-1 Lineages Circulating among Treatment-naïve Individuals Stephane Hue*¹, R Gifford², D Dunn³, E Fernhill³, and D Pillay¹ ¹Univ Coll London, UK; ²Stanford Univ, CA, US; and ³Med Res Council, London, UK
676	Transmitted HIV Drug Resistance May Originate from Untreated and Undiagnosed Individuals: A Phylogenetic Exploration Alison Brown*^1,2, D Sudarshi³, M Fisher³, D Pao³, A Buckton¹, A Johnson², P Cane¹, N Gill¹, and D Pillay^1,2 ¹Hlth Protection Agency, London, UK; ²Univ Coll London, UK; and ³Brighton and Sussex Univ Hosp, UK
677	Transmission Networks of Resistant HIV-1 among Men Who Have Sex with Men: The Netherlands Daniela Bezemer*^1,2, A Van Sighem^1,2, V Lukashov², L Van Der Hoek², S Jurriaans², R Schuurman³, C Boucher⁴, E Claas⁵, R Coutinho⁶, F De Wolf^1,2,7, and the ATHENA Observational Cohort ¹HIV Monitoring Fndn, The Netherlands; ²Academic Med Ctr, Univ of Amsterdam, The Netherlands; ³Univ Med Ctr, Utrecht, The Netherlands; ⁴Erasmus Med Ctr, Rotterdam, The Netherlands; ⁵Leiden Univ Med Ctr, The Netherlands; ⁶Natl Inst for Publ Hlth and the Environment, Bilthoven, The Netherlands; and ⁷Imperial Coll London, UK
678	The Paradox of Pre-exposure Prophylaxis: Effects on Incidence and Transmitted Resistance in San Francisco Virginie Supervie*¹, G García-Lerma², W Heneine², and S Blower¹ ¹Semel Inst for Neurosci and Human Behavior, David Geffen Sch of Med, Univ of California, Los Angeles, US and ²CDC, Atlanta, GA, US